ESCRS - PE052 - Comparative Study Of Pretarsal Height In Primary Congenital Glaucoma On Topical Pg Analogue

Comparative Study Of Pretarsal Height In Primary Congenital Glaucoma On Topical Pg Analogue

Published 2022 - 40th Congress of the ESCRS

Reference: PE052 | Type: ESONT - Abstract | DOI: 10.82333/aryk-5m56

Authors: Dhwanee Agarwal*

Purpose

To draw a comparison between the change in the Pretarsal Height (PTH) of children having primary congenital glaucoma (PCG) on topical prostaglandin analogue (PGA) with children having PCG not on PGA.

Setting/Venue

VMMC and Safrdarjung Hospital, New Delhi, India

Methods

The study population included children below 10 years of age with PCG for at least 6 months. 20 were started on TPA (Group 1) and 22 were control (Group 2). Pretarsal height was taken as an indicator for deepening of sulcus of eyelids. 

Results

A significant change in the PTH was seen between the two group. Mean difference was ≥1.2mm (p< 0.02)

Conclusions

As there was significant increase in the PTH of children with PCG, started of PGA, it is essential to counsel the family about possible future periorbitopathy.

No financial disclosures of the author.